[b]$IMMB[/b] [b]Please Read Key Post( Edited Feb.8th ) >> As you can see the market here is wide open for growth and by 2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB![/b]
Why is that important to IMMB, there is simply room for Competitors and definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday.
[b]Well here is my take as to WHY you should BUY IMMB....
[/b]
[b]IMMB currently carries 4 patents one of which is the coveted HIV/AIDS PATENT valued at over $5 Million[/b] >> http://imagehost.vendio.com/a/8709739/view/Patent.png
So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create key patents... IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents. ...Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so on October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors .
Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell!
As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.
So now we have a growing Board with TOP notch Members whom carry HUGE connections.
[b]Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided[/b] >> http://www.otcmarkets.com/stock/IMMB/news
[b]Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients
[/b]
[b]Followed by a much BIGGER News RELEASE JAN/2013 Link Provided[/b] >> http://www.otcmarkets.com/stock/IMMB/news
[b]Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines
[/b]
[b]Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided[/b] >> http://ih.advfn.com/p.php?pid=nmona&article=56128728
[b]Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures
[/b]
[b]A Follow up to the newly appointed Dimitrov[/b] >> http://ih.advfn.com/p.php?pid=nmona&article=56190456
[b]Immunotech Laboratories Appoints New Chief Financial Advisor to Strengthen Company's Growth and International Expansion Plan
[/b]
[b]If you are still with me you are now adding everything up and saying to yourself HOLY SH*T, We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE...
[/b]
[b]KEY STATEMENTS FORM LAST PR >>
[/b]
Immunotech President Harry Zhabilov commented, "We are very pleased to announce the appointment of Valentin to the Board of Directors and feel he will be a valuable member of our team, and significantly help accelerate the progression of the company towards FDA approval for the 'IPF' technology. "
[b]The appointment of Mr. Dimitrov to Immunotech's Board of Directors helps with the potential goal of upgrading the company to the NASDAQ exchange, where a minimum of 5 Board Members are required .
[/b]
[b]From the 2ND last PR and in the words of MR.BO LINTON (read BOLD)[/b]>>
Mr. Linton further commented the company recently received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug" . [b]If confirmed the initial order would be in excess of several Million Dollars . This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company[/b] . In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.
[b]Now that you are seeing what I am seeing I will show you the KICKER[/b] >>
[b]CURRENT SHARE STRUCTURE
[/b]
OUTSTANDING SHARES 60,500,000 give or take a handful
[b]FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON (link provided ) [/b]>> http://www.otcmarkets.com/stock/IMMB/news
AUTHORIZED 150,000,000 (MAY BE HIGHER)
[b]Want More, I have more[/b] >>
[b]INSIDERS HOLDINGS 98% of O/S Here is the PROOF[/b] >>
Name of Shareholder Number of Shares
Harry Zhabilov 24,895,646 41.11
Ara Ghanime 24,895,646 41.11
Dow Jones Link 2,773,500 4.58
Allie Chang 600,000 1.0
Paul Felizian 600,000 1.0
Lord George Equities 5,400,000 9.0
Joseph Pittera 250,000 0.41
Harout Tovmasyan 151,000 0.25
Elie Sakayan 50,000 0.08
Hagop Parseghian 600,000 1.0
Others 339,896 0.46
So there you have it!
[b]PS since last Wednesday JAN.30TH in case you missed it we have seen 587,375 Shares TRADED or for the most part BOUGHT and we are up from .06 to .39 majority bought at .25-.45 & MAJOR NEWS PENDING[/b]....with that said we have seen [b]MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM![/b]
Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.
Your Friend Cheeky!
[b]PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above![/b]
